Savira, Roche in influenza deal

Savira Pharmaceuticals GmbH (Vienna, Austria) granted Roche (SIX:ROG; OTCQX:RHHBY) exclusive, worldwide rights to its small molecule program targeting the "cap-snatching mechanism" of influenza polyme...